1. Home
  2. HUMA vs DBI Comparison

HUMA vs DBI Comparison

Compare HUMA & DBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Humacyte Inc.

HUMA

Humacyte Inc.

HOLD

Current Price

$0.72

Market Cap

308.6M

Sector

Health Care

ML Signal

HOLD

Logo Designer Brands Inc.

DBI

Designer Brands Inc.

HOLD

Current Price

$6.24

Market Cap

315.8M

ML Signal

HOLD

Company Overview

Basic Information
Metric
HUMA
DBI
Founded
2004
1991
Country
United States
United States
Employees
184
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Clothing/Shoe/Accessory Stores
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
308.6M
315.8M
IPO Year
N/A
2005

Fundamental Metrics

Financial Performance
Metric
HUMA
DBI
Price
$0.72
$6.24
Analyst Decision
Strong Buy
Hold
Analyst Count
8
2
Target Price
$6.19
$6.75
AVG Volume (30 Days)
13.4M
879.8K
Earning Date
05-15-2026
06-09-2026
Dividend Yield
N/A
2.73%
EPS Growth
N/A
15.00
EPS
N/A
0.02
Revenue
N/A
$2,892,671,000.00
Revenue This Year
$444.16
$1.29
Revenue Next Year
$248.39
$1.88
P/E Ratio
N/A
$294.50
Revenue Growth
N/A
N/A
52 Week Low
$0.55
$2.37
52 Week High
$2.84
$9.17

Technical Indicators

Market Signals
Indicator
HUMA
DBI
Relative Strength Index (RSI) 37.45 41.31
Support Level $0.60 $6.13
Resistance Level $1.28 $8.05
Average True Range (ATR) 0.12 0.53
MACD -0.07 -0.14
Stochastic Oscillator 16.20 9.89

Price Performance

Historical Comparison
HUMA
DBI

About HUMA Humacyte Inc.

Humacyte Inc is developing a commercial-stage biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

About DBI Designer Brands Inc.

Designer Brands Inc is a designer, producer, and retailer of footwear and accessories. The company operates in two reportable segments: the Retail segment and the Brand Portfolio segment. The Retail segment, which derives key revenue, operates the DSW Designer Shoe Warehouse ("DSW") banner through its direct-to-consumer stores and e-commerce sites in the United States ("U.S.") and Canada, and the Shoe Co. and Rubino banners through its direct-to-consumer stores and e-commerce sites in Canada. The Brand Portfolio segment principally earns revenue from the wholesale of its exclusive and licensed brands to retailers, its Retail segment, and international distributors, and the sale of its Vince Camuto, Keds, and Topo brands through direct-to-consumer e-commerce sites.

Share on Social Networks: